TrialBritish journal of haematology2011

A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers.

Steven J Lemery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.